City of Hope

www.cityofhope.org

 

Insights from 2023 ASCO® Annual Meeting
H

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"

By Insights from 2023 ASCO® Annual Meeting FEATURING Haris Ali
By Insights from 2023 ASCO® Annual Meeting FEATURING Haris Ali
205 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Hematologic Malignancies
12:13

New

Sequencing T-Cell Therapies in Relapsed Myeloma: BCMA, Bispecifics, …

City of Hope

A. Krishnan

14 views
09:42

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Pr…

2024 ASCO® Annual Meeting Insights Hub

M. Al Malki

274 views
27:47

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

City of Hope

I. Amanam

202 views
08:46

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor …

Insights from 2023 ASCO® Annual Meeting

H. Ali

205 views
16:27

Transplant Optimization in Older Adults With Hematologic Malignancie…

City of Hope

A. Artz

21 views